Oral Rogaine maker Veradermics looks to raise $181M from IPO

Veradermics, a biotech in late-stage testing with an oral version of Rogaine, is looking to raise $181.8 million in net proceeds from its proposed IPO. The Connecticut biotech will garner that amount if it sells ...